$140 Original price was: $140.$110Current price is: $110.
Zycortal is a prolonged-release subcutaneous injection (desoxycortone pivalate / DOCP 25mg/ml) for mineralocorticoid replacement in dogs with primary Addison’s disease (hypoadrenocorticism). 4ml vial (100mg). Initial dose 2.2mg/kg SC; dose adjusted via Na+/K+ ratio monitoring. Given every 25–40 days. Always used alongside prednisolone for glucocorticoid replacement. Store refrigerated at 2–8°C.
| ACTIVE INGREDIENT | Desoxycortone pivalate 25 mg/ml |
|---|---|
| ANIMALS | Dogs |
| FORM | Suspension |
13 people are viewing this product right now
🔥 10 items sold in last 3 hours
Best prices
Always FREE delivery
Huge product selection. You can contact us if you need certain product
Zycortal is a prolonged-release injectable suspension manufactured by Dechra Animal Health, containing desoxycortone pivalate (DOCP) 25mg/ml. It is used for long-term mineralocorticoid replacement therapy in dogs with primary hypoadrenocorticism (Addison’s disease) that have lost the ability to produce sufficient aldosterone from their adrenal glands.
Each 4ml vial contains 100mg desoxycortone pivalate. Zycortal is administered by subcutaneous injection approximately every 25–40 days, with the exact dose and interval adjusted to each individual dog based on clinical response and electrolyte monitoring.
The adrenal glands sit above the kidneys and produce two essential categories of hormones:
In Addison’s disease (primary hypoadrenocorticism), the adrenal cortex is destroyed — most commonly by immune-mediated attack — and production of both hormone types fails. The consequences of mineralocorticoid deficiency are particularly life-threatening:
Zycortal replaces the missing mineralocorticoid function. It does not replace glucocorticoids — most dogs with Addison’s disease also require concurrent prednisolone to address the glucocorticoid deficiency.
Desoxycortone pivalate is a synthetic mineralocorticoid that mimics aldosterone’s actions at the mineralocorticoid receptors in the renal tubules. It promotes:
The pivalate ester formulation creates a depot effect after subcutaneous injection: the drug is slowly released from the injection site over several weeks rather than being absorbed immediately, providing prolonged activity from a single injection. Peak blood concentrations (Tmax) occur approximately 10 days after injection, and the plasma half-life is approximately 17 days. This pharmacokinetic profile allows dosing intervals of approximately 25–40 days in most dogs.
This is the most clinically critical point about Zycortal. It provides mineralocorticoid replacement only. Dogs with primary Addison’s disease have combined mineralocorticoid and glucocorticoid deficiency. Without glucocorticoid replacement (prednisolone or hydrocortisone), the dog will remain ill despite Zycortal treatment.
The standard management of Addison’s disease requires:
Your veterinarian will prescribe both components and adjust each based on the dog’s response and monitoring results.
The starting dose is 2.2mg/kg body weight administered as a single subcutaneous injection.
| Dog Weight | Initial Dose (2.2mg/kg) | Volume of Zycortal 25mg/ml | 4ml Vial Covers |
|---|---|---|---|
| 5 kg | 11 mg | 0.44 ml | ~9 doses |
| 10 kg | 22 mg | 0.88 ml | ~4.5 doses |
| 15 kg | 33 mg | 1.32 ml | ~3 doses |
| 20 kg | 44 mg | 1.76 ml | ~2.3 doses |
| 25 kg | 55 mg | 2.20 ml | ~1.8 doses |
| 30 kg | 66 mg | 2.64 ml | ~1.5 doses |
| 40 kg | 88 mg | 3.52 ml | ~1.1 doses |
| 45 kg | 99 mg | 3.96 ml | ~1 dose (near full vial) |
The 4ml vial (100mg total) provides approximately one full dose for a 45kg dog. For smaller dogs, vials can be used across multiple doses under aseptic technique if your vet advises this. Always use a graduated syringe for accurate dose measurement.
The Zycortal dosing protocol is individualised based on serum Na+/K+ ratio monitoring. The normal target Na+/K+ ratio is 27–32.
Approximately 10 days after the first injection (which is the time of peak drug concentration), measure the serum Na+/K+ ratio. Use these results to determine how to adjust the second dose (given on approximately Day 25):
| Na+/K+ Ratio at Day 10 | Action for Dose 2 |
|---|---|
| ≥ 34 | Reduce dose to 2.0 mg/kg |
| 32 to < 34 | Reduce dose to 2.1 mg/kg |
| 27 to < 32 (normal) | Continue with 2.2 mg/kg |
| 24 to < 27 | Increase dose to 2.3 mg/kg |
| < 24 | Increase dose to 2.4 mg/kg |
Approximately 25 days after the first injection, reassess the dog’s clinical status and Na+/K+ ratio:
Once the optimal dose and interval are established, they are maintained consistently. In the Zycortal clinical trial:
| Clinical Signs | Electrolyte Status | Action |
|---|---|---|
| Polyuria/polydipsia | Na+/K+ > 32 (over-mineralised) | First reduce prednisolone; if persists, reduce Zycortal dose |
| Depression, lethargy, vomiting, diarrhoea, weakness | Any | Increase prednisolone dose first |
| Hyperkalaemia or hyponatraemia (Na+/K+ < 27) | Under-mineralised | Shorten dosing interval by 2–3 days, OR increase Zycortal dose |
| Hypokalaemia or hypernatraemia (Na+/K+ > 32) | Over-mineralised | Reduce Zycortal dose |
An Addisonian crisis is a life-threatening emergency. A dog in Addisonian crisis must NOT receive Zycortal as the first treatment. Before Zycortal is started, a dog with severe hypovolaemia, dehydration, pre-renal azotaemia, and cardiovascular compromise requires:
If your dog is acutely unwell — collapsed, severely depressed, vomiting, unable to stand — this is a veterinary emergency. Do not attempt to give Zycortal at home. Seek emergency veterinary care immediately.
Dogs with Addison’s disease cannot produce extra cortisol in response to stress (surgery, illness, travel, trauma). Before any anticipated stressful event:
| Drug | Interaction | Action |
|---|---|---|
| Trimethoprim (TMP-SMX) | May alter serum potassium levels | Use with caution; monitor electrolytes |
| Amphotericin B | Potassium-wasting; additive hypokalaemia | Monitor potassium closely |
| Digoxin | Hypokalaemia increases digoxin toxicity risk | Monitor potassium; avoid over-mineralisation |
| Insulin | May affect potassium transport | Monitor electrolytes; adjust insulin as needed in diabetic patients |
⚠️ Refrigerate: Store at 2°C – 8°C (36°F – 46°F). Do not freeze.
| Feature | Zycortal (DOCP / Desoxycortone pivalate) | Fludrocortisone |
|---|---|---|
| Route | Subcutaneous injection | Oral tablets (daily) |
| Frequency | Every 25–40 days | Once or twice daily |
| Mineralocorticoid activity | Pure mineralocorticoid only | Predominantly mineralocorticoid with some glucocorticoid activity |
| Additional prednisolone needed? | Yes — always required | Sometimes not, depending on degree of glucocorticoid deficiency |
| Dose titration | Via Na+/K+ ratio monitoring every 25 days initially | Via Na+/K+ ratio monitoring; dose adjustment often needed over time |
| Owner compliance challenge | Regular clinic visits for injection | Daily tablet administration at home |
| Advantage | No daily medication; consistent depot release; easier compliance for many owners | Oral dosing, no injections needed |
Yes — almost certainly. Zycortal only replaces mineralocorticoid function. The adrenal cortex in dogs with primary Addison’s disease also fails to produce glucocorticoids (cortisol). Without prednisolone (or another glucocorticoid) to replace this, dogs remain unwell despite Zycortal treatment. Most Addison’s dogs are managed with both Zycortal every 25–40 days AND daily prednisolone at physiological doses. Discuss the combined management plan with your veterinarian.
By monitoring the serum sodium/potassium (Na+/K+) ratio. A ratio of 27–32 is the target. Your vet will check this at Day 10 and Day 25 initially to adjust the dose. Once stable, electrolytes are typically checked every 3–6 months. Clinical signs — particularly excessive thirst/urination or returning weakness — should prompt an earlier check.
The mineralocorticoid effect of the previous dose gradually wanes. The dog may begin showing signs of mineralocorticoid deficiency: lethargy, reduced appetite, vomiting, weakness, and in severe cases collapse (Addisonian crisis). If a dose is delayed, contact your veterinarian — do not simply give the next scheduled dose without electrolyte assessment, as the dog may need emergency treatment.
Zycortal is a subcutaneous injection. Some veterinarians teach owners to administer it at home once the technique and dose have been established. However, the associated electrolyte monitoring (blood tests) must be conducted at the veterinary clinic. Discuss home administration with your vet.
It depends entirely on your dog’s weight. At the initial dose of 2.2mg/kg: a 10kg dog needs 0.88ml (about 4.5 doses per vial); a 20kg dog needs 1.76ml (about 2.3 doses per vial); a 40kg dog needs 3.52ml (about 1 full dose per vial). For most medium-to-large dogs, one vial per injection visit is practical. See the dosage table above for your dog’s weight.
Related products: Prednisolone 5mg Tablets – Glucocorticoid for Addison’s disease co-management
You must be logged in to post a review.
Reviews
There are no reviews yet.